欧州の細胞・遺伝子治療用解凍装置市場 – 業界動向と2028年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

欧州の細胞・遺伝子治療用解凍装置市場 – 業界動向と2028年までの予測

  • Healthcare
  • Published Report
  • Sep 2021
  • Europe
  • 350 ページ
  • テーブル数: 151
  • 図の数: 55

>ヨーロッパの細胞および遺伝子治療解凍装置市場、モダリティ(ベンチトップ型およびポータブル型)、サンプル(細胞治療および遺伝子治療)、タイプ(手動解凍システムおよび自動解凍システム)、アプリケーション(上流処理および下流処理)、エンドユーザー(血液銀行および輸血センター、病院および診断研究所、研究研究所および学術機関、バイオテクノロジーおよび製薬業界、臍帯血および幹細胞バンク、遺伝子バンクなど)、流通チャネル(直接入札、第三者販売業者など)、国(英国、ドイツ、フランス、スペイン、イタリア、オランダ、スイス、ロシア、ベルギー、トルコ、アイルランド、その他のヨーロッパ諸国)別の2028年までの業界動向および予測。

欧州の細胞・遺伝子治療用解凍装置市場市場分析と洞察: ヨーロッパの細胞および遺伝子治療用解凍装置市場

細胞および遺伝子治療用解凍装置市場は、2021年から2028年の予測期間に市場が成長すると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に13.3%のCAGRで成長し、2028年までに4億4,415万米ドルに達すると分析しています。慢性疾患の蔓延により、高度な細胞および遺伝子治療用解凍装置ソリューションとサービスが求められており、細胞および遺伝子治療用解凍装置市場の成長の原動力となっています。

技術の進歩により、細胞および遺伝子治療用解凍装置は、多くの主要市場プレーヤーが市場拡大のために新しいソリューションを開発し、発売するにつれて、簡単に利用できるようになりました。さらに、先進国だけでなく発展途上国でも医療費の増加が、細胞および遺伝子治療用解凍装置市場の成長を後押ししています。細胞および遺伝子治療用解凍装置市場は、慢性疾患の発生率の増加と技術の進歩により成長しています。

慢性疾患の罹患率の増加は、細胞および遺伝子治療用解凍装置市場の原動力となっています。細胞および遺伝子治療工学に関連するコストの上昇により、細胞および遺伝子治療用解凍装置の需要が低下し、細胞および遺伝子治療用解凍装置市場の成長が抑制されています。新しい技術進歩の急増は、細胞および遺伝子治療用解凍装置市場にとってチャンスとなっています。しかし、低所得国および中所得国でのアクセスの欠如は、細胞および遺伝子治療用解凍装置市場の成長にとって課題となっています。

細胞および遺伝子治療用解凍装置市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析と細胞および遺伝子治療用解凍装置市場のシナリオを理解するには、アナリスト概要について Data Bridge Market Research にお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。

欧州の細胞・遺伝子治療用解凍装置市場細胞および遺伝子治療用解凍装置の市場範囲と市場規模

細胞および遺伝子治療用解凍装置市場は、モダリティ、サンプル、タイプ、アプリケーション、エンドユーザー、流通チャネルに基づいてセグメント化されています。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コアアプリケーション領域とターゲット市場の違いを決定するのに役立ちます。

  • サンプルに基づいて、細胞および遺伝子治療解凍装置市場は、細胞治療と遺伝子治療に分類されます。2021年には、がんの有病率と発生率の上昇により、細胞治療セグメントが細胞および遺伝子治療解凍装置市場を支配すると予想されます。 
  • タイプに基づいて、細胞および遺伝子治療用解凍装置市場は、手動解凍システムと自動解凍システムに分類されます。2021年には、再現性を向上させ、人的エラーを最小限に抑える自動解凍システムセグメントが細胞および遺伝子治療用解凍装置市場を支配すると予想されます。 
  • 用途に基づいて、細胞および遺伝子治療用解凍装置市場は、上流処理と下流処理に分類されます。2021年には、解凍システムの技術的進歩の高まりにより、上流処理セグメントが細胞および遺伝子治療用解凍装置市場を支配すると予想されます。 
  • エンドユーザーに基づいて、細胞および遺伝子治療解凍装置市場は、血液銀行および輸血センター、病院および診断研究所、研究室および学術機関、バイオテクノロジーおよび製薬業界、臍帯血および幹細胞バンク、遺伝子バンク、その他に分類されます。 2021年には、低所得国および中所得国における血液銀行と高度な医療提供者の増加により、血液銀行セグメントが細胞および遺伝子治療解凍装置市場を支配すると予想されます。
  • 流通チャネルに基づいて、細胞および遺伝子治療解凍装置市場は、直接入札、サードパーティの販売代理店、その他に分類されます。 2021年には、医療提供者の大多数が直接入札から細胞および遺伝子治療解凍装置を調達するため、直接入札セグメントが細胞および遺伝子治療解凍装置市場を支配すると予想されます。

細胞および遺伝子治療用解凍装置市場の国別分析

細胞および遺伝子治療解凍装置市場は、モダリティ、サンプル、タイプ、アプリケーション、エンドユーザー、流通チャネルに基づいてセグメント化されています。

細胞および遺伝子治療用解凍装置市場レポートで取り上げられている国は、ドイツ、フランス、スペイン、イタリア、オランダ、スイス、ロシア、トルコ、オーストリア、アイルランド、その他のヨーロッパ諸国です。

ドイツは技術の進歩により欧州市場を支配すると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

細胞および遺伝子治療用解凍装置に対する認知度を高めるために主要な市場プレーヤーが戦略的な活動を拡大し、細胞および遺伝子治療用解凍装置市場の成長を後押ししています。

細胞および遺伝子治療用解凍装置市場では、特定の市場における各国の成長に関する詳細な市場分析も提供されます。さらに、市場プレーヤーの戦略と地理的なプレゼンスに関する詳細情報も提供されます。データは、2010 年から 2019 年までの履歴期間について利用可能です。

競争環境と細胞・遺伝子治療用解凍装置の市場シェア分析

細胞および遺伝子治療解凍装置市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線などがあります。提供された上記のデータポイントは、細胞および遺伝子治療解凍装置市場に関連する会社の焦点にのみ関連しています。

細胞および遺伝子治療用解凍装置を扱っている主な企業としては、Pluristem Therapeutics Inc.、Genesis BPS、Eppendorf AG、Cytiva(Danaher Corporation の子会社)、Glenmark Pharmaceutical Inc.、USA(Glenmark の子会社)、EDGE pharma、Cook、SARSTEDT AG & Co. KG、Barkey、Boekel Scientific、LABCOLD、Sartorious AG、Helmer Scientific Inc. などがあり、その他国内企業も含まれています。DBMR のアナリストは、競争上の強みを理解し、各競合他社の競合分析を個別に提供しています。

世界中の企業によって多くの契約や協定も開始されており、細胞および遺伝子治療の解凍装置市場も加速しています。

例えば、

  • 2020 年 11 月、Eppendorg AG はインドで細胞解凍用 SmartBlock を発売しました。細胞解凍用 Smart Block は下流処理の基盤です。科学者にとって、あらゆる細胞処理ラボでの使用が簡単で便利です。

市場プレーヤーによるコラボレーション、製品の発売、事業拡大、賞や表彰、合弁事業、その他の戦略は、細胞および遺伝子治療解凍装置市場における企業の足跡を強化し、組織の利益成長にも利益をもたらします。


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 USAGE OF THAWING EQUIPMENT IN UPSTREAM AND DOWNSTREAM PROCESSES

5.1 UPSTREAM PROCESS

5.2 DOWNSTREAM PROCESS

6 CELL AND GENE THERAPY WORKFLOW USING THAWING EQUIPMENT

7 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: REGULATIONS

7.1 CANADA

7.2 THE U.S.

7.3 EUROPE

7.4 GENE THERAPY LEGISLATION IN AUSTRIA

7.5 GENE THERAPY LEGISLATION IN BULGARIA

7.6 JAPAN

7.7 ITALY

7.8 MALAYSIA

8 REGIONAL SUMMARY

9 MARKET OVERVIEW

9.1 DRIVERS

9.1.1 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CYSTIC FIBROSIS AND SICKLE CELL ANEMIA

9.1.2 RISE IN INVESTMENT IN R&D FOR DEVELOPMENT OF CELL AND GENE THERAPIES

9.1.3 GOVERNMENT INITIATIVES FOR INITIATION OF CELL AND GENE THERAPY FIELD

9.1.4 INCREASED IMPLEMENTATION OF ADENO-ASSOCIATED VIRUS

9.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE THAWING SYSTEMS

9.2 RESTRAINTS

9.2.1 RISE IN COST ASSOCIATED WITH CELL AND GENE THERAPY ENGINEERING

9.2.2 RISE OF UNWANTED MUTAGENS

9.2.3 TECHNICAL HINDRANCE FACED IN USING THAWING INSTRUMENTS

9.2.4 STRICT REGULATORY FRAMEWORK

9.3 OPPORTUNITIES

9.3.1 INCREASING PREVALENCE OF CANCER

9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS

9.3.3 RISE IN EXPENDITURE IN HEALTHCARE SECTOR

9.4 CHALLENGES

9.4.1 LONG APPROVAL TIME FOR IMMUNOTHERAPIES

9.4.2 LACK OF ACCESSIBILITY

10 IMPACT OF COVID-19 ON EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

10.1 IMPACT ON PRICE

10.2 IMPACT ON DEMAND

10.3 IMPACT ON SUPPLY CHAIN

10.4 STRATEGIC DECISION FOR MANUFACTURERS

10.5 CONCLUSION

11 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY

11.1 OVERVIEW

11.2 BENCH TOP

11.3 PORTABLE

12 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE

12.1 OVERVIEW

12.2 CELL THERAPIES

12.2.1 CAR T CELLS

12.2.2 NK CELLS

12.2.3 MSCS

12.2.4 TILS

12.2.5 OTHERS

12.3 GENE THERAPIES

12.3.1 ADENOVIRUS

12.3.2 ADENO-ASSOCIATED VIRUSES

12.3.3 LENTIVIRUSES

12.3.4 ONCOLYTIC VIRUSES

12.3.5 OTHERS

13 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE

13.1 OVERVIEW

13.2 AUTOMATIC THAWING SYSTEM

13.3 MANUAL THAWING SYSTEM

14 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION

14.1 OVERVIEW

14.2 UPSTREAM PROCESSING

14.2.1 AUTOMATIC THAWING SYSTEM

14.2.2 MANUAL THAWING SYSTEM

14.3 DOWNSTREAM PROCESSING

14.3.1 AUTOMATIC THAWING SYSTEM

14.3.2 MANUAL THAWING SYSTEM

15 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER

15.1 OVERVIEW

15.2 HOSPITALS AND DIAGNOSTIC LABORATORIES

15.3 BLOOD BANKS AND TRANSFUSION CENTERS

15.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES

15.5 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY

15.6 CORD BLOOD AND STEM CELL BANKS

15.7 GENE BANKS

15.8 OTHERS

16 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 DIRECT TENDER

16.3 THIRD PARTY DISTRIBUTORS

16.4 OTHERS

17 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION

17.1 EUROPE

17.1.1 GERMANY

17.1.2 FRANCE

17.1.3 U.K.

17.1.4 ITALY

17.1.5 SPAIN

17.1.6 RUSSIA

17.1.7 TURKEY

17.1.8 BELGIUM

17.1.9 NETHERLANDS

17.1.10 SWITZERLAND

17.1.11 LUXEMBOURG

17.1.12 REST OF EUROPE

18 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: EUROPE

19 SWOT ANALYSIS

20 COMPANY PROFILE

20.1 MERCK KGAA

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 PRODUCT PORTFOLIO

20.1.4 RECENT DEVELOPMENTS

20.2 EPPENDORF AG

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 PRODUCT PORTFOLIO

20.2.4 RECENT DEVELOPMENTS

20.3 SARTORIUS AG

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENT

20.4 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)

20.4.1 COMPANY SNAPSHOT

20.4.2 REVENUE ANALYSIS

20.4.3 PRODUCT PORTFOLIO

20.4.4 .RECENT DEVELOPMENTS

20.5 BARKEY

20.5.1 COMPANY SNAPSHOT

20.5.2 PRODUCT PORTFOLIO

20.5.3 RECENT DEVELOPMENTS

20.6 BOEKEL SCIENTIFIC

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 BIOLINE INDIA

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENTS

20.8 COOK

20.8.1 COMPANY SNAPSHOT

20.8.2 PRODUCT PORTFOLIO

20.8.3 RECENT DEVELOPMENT

20.9 GENESIS BPS

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENTS

20.1 HELMER SCIENTIFIC INC.

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENTS

20.11 LABCOLD

20.11.1 COMPANY SNAPSHOT

20.11.2 PRODUCT PORTFOLIO

20.11.3 RECENT DEVELOPMENTS

20.12 PLEURISTEM THERAPEUTICS INC.

20.12.1 COMPANY SNAPSHOT

20.12.2 REVENUE ANALYSIS

20.12.3 PRODUCT PORTFOLIO

20.12.4 RECENT DEVELOPMENTS

20.13 SARSTEDT AG & CO. KG

20.13.1 COMPANY SNAPSHOT

20.13.2 PRODUCT PORTFOLIO

20.13.3 RECENT DEVELOPMENTS

21 QUESTIONNAIRE

22 RELATED REPORTS

表のリスト

TABLE 1 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)

TABLE 2 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 3 EUROPE BENCH TOP IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 EUROPE PORTABLE IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 6 EUROPE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 EUROPE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 8 EUROPE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 EUROPE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 10 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 11 EUROPE AUTOMATIC THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 EUROPE MANUAL THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 14 EUROPE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 EUROPE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 EUROPE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 EUROPE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 18 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 19 EUROPE HOSPITALS AND DIAGNOSTIC LABORATORIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 EUROPE BLOOD BANKS AND TRANSFUSION CENTERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 EUROPE RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 EUROPE CORD BLOOD AND STEM CELL BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 EUROPE GENE BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 EUROPE OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 27 EUROPE DIRECT TENDER IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 EUROPE THIRD PARTY DISTRIBUTORS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 EUROPE OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 31 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 32 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 33 EUROPE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 34 EUROPE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 35 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 36 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 37 EUROPE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 38 EUROPE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 39 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 40 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 42 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 43 GERMANY CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 44 GERMANY GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 45 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 GERMANY UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 GERMANY DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 50 GERMANY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 52 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 53 FRANCE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 54 FRANCE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 55 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 FRANCE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 58 FRANCE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 FRANCE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 62 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 63 U.K. CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 64 U.K. GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 65 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 U.K. UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 U.K. DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 70 U.K. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 72 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 73 ITALY CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 74 ITALY GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 75 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 77 ITALY UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 ITALY DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 80 ITALY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 82 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 83 SPAIN CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 84 SPAIN GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 85 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 87 SPAIN UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 88 SPAIN DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 90 SPAIN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 91 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 92 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 93 RUSSIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 94 RUSSIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 95 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 96 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 RUSSIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 98 RUSSIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 99 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 RUSSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 102 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 103 TURKEY CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 104 TURKEY GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 105 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 106 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 107 TURKEY UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 TURKEY DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 109 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 110 TURKEY CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 111 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 112 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 113 BELGIUM CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 114 BELGIUM GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 115 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 116 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 117 BELGIUM UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 118 BELGIUM DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 119 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 120 BELGIUM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 121 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 122 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 123 NETHERLAND CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 124 NETHERLAND GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 125 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 126 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 127 NETHERLAND UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 128 NETHERLAND DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 129 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 130 NETHERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 131 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 132 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 133 SWITZERLAND CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 134 SWITZERLAND GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 135 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 136 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 137 SWITZERLAND UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 SWITZERLAND DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 139 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 140 SWITZERLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 141 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 142 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 143 LUXEMBOURG CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 144 LUXEMBOURG GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 145 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 146 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 147 LUXEMBOURG UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 148 LUXEMBOURG DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 149 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 150 LUXEMBOURG CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 151 REST OF EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

図表一覧

FIGURE 1 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION

FIGURE 2 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DROC ANALYSIS

FIGURE 4 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION

FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CARDIAC AILMENTS, CYSTIC FIBROSIS AND AIDS IS EXPECTED TO DRIVE THE EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN 2021 & 2028

FIGURE 15 PESTEL ANALYSIS

FIGURE 16 PORTERS FIVE FORCES MODEL

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

FIGURE 18 INCIDENCE OF CYSTIC FIBROSIS OBSERVED IN THE COUNTRIES

FIGURE 19 PREVALENCE OF SICKLE CELL ANEMIA IN AFRICA AND EUROPE

FIGURE 20 NEW CANCER CASES WORLDWIDE, (2018) (IN MILLION)

FIGURE 21 EUROPE CANCER INCIDENCE (2018)

FIGURE 22 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2020

FIGURE 23 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2021-2028 (USD MILLION)

FIGURE 24 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, CAGR (2021-2028)

FIGURE 25 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 26 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2020

FIGURE 27 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2021-2028 (USD MILLION)

FIGURE 28 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, CAGR (2021-2028)

FIGURE 29 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY SAMPLE, LIFELINE CURVE

FIGURE 30 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2020

FIGURE 31 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2021-2028 (USD MILLION)

FIGURE 32 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, CAGR (2021-2028)

FIGURE 33 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 34 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2020

FIGURE 35 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 36 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 37 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 38 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2020

FIGURE 39 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 40 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 41 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 43 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 44 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 45 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 46 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SNAPSHOT (2020)

FIGURE 47 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020)

FIGURE 48 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 49 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 50 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY (2021-2028)

FIGURE 51 EUROPE CELL AND GENE THERAPY THAWING EQUIPMENTMARKET: COMPANY SHARE 2020 (%)

FIGURE 52 COMPANY SHARE ANALYSIS

FIGURE 53 COMPANY SHARE ANALYSIS

FIGURE 54 COMPANY SHARE ANALYSIS

FIGURE 55 COMPANY SHARE ANALYSIS

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。